Cargando…
Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis
Patients suffering from allergic rhinitis often attempt to self-manage their symptoms and may seek advice from pharmacists about nonprescription product choices. Several drug classes, both prescription and over-the-counter (OTC), are available, including intranasal corticosteroids (INCSs); oral, int...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774310/ https://www.ncbi.nlm.nih.gov/pubmed/29354557 http://dx.doi.org/10.2147/IPRP.S129544 |
_version_ | 1783293735228932096 |
---|---|
author | Bridgeman, Mary Barna |
author_facet | Bridgeman, Mary Barna |
author_sort | Bridgeman, Mary Barna |
collection | PubMed |
description | Patients suffering from allergic rhinitis often attempt to self-manage their symptoms and may seek advice from pharmacists about nonprescription product choices. Several drug classes, both prescription and over-the-counter (OTC), are available, including intranasal corticosteroids (INCSs); oral, intranasal, and ocular antihistamines; leukotriene antagonists; and topical and systemic decongestants, as well as immunotherapies. Selection of the optimal treatment approach depends on the temporal pattern, frequency, and severity of symptoms as well as the patient’s age. Nasal congestion is typically the most bothersome symptom, although rhinorrhea, postnasal drip, and ocular symptoms are also problematic. Together, these symptoms may adversely impact the quality of life, work productivity, sleep quality, and the ability to perform daily activities, particularly when uncontrolled. Practice guidelines recognize that INCSs are the most effective medications for controlling allergic rhinitis symptoms, including nasal congestion. Available INCS products have comparable safety and efficacy profiles, but they differ in formulation characteristics and sensory attributes. Several barriers can impede the use of INCSs, including concerns about safety, misperceptions regarding the loss of response from frequent use, and undesirable sensations associated with intranasal administration. Given the increasing number of INCSs available OTC, pharmacists can help allay these concerns by discussing treatment expectations, recommending INCS products with favorable formulation characteristics, and reviewing proper use and technique for the administration of the selected product. These steps can help to foster a collaborative relationship between the patient and the pharmacist in the treatment of allergic rhinitis. |
format | Online Article Text |
id | pubmed-5774310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57743102018-01-19 Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis Bridgeman, Mary Barna Integr Pharm Res Pract Review Patients suffering from allergic rhinitis often attempt to self-manage their symptoms and may seek advice from pharmacists about nonprescription product choices. Several drug classes, both prescription and over-the-counter (OTC), are available, including intranasal corticosteroids (INCSs); oral, intranasal, and ocular antihistamines; leukotriene antagonists; and topical and systemic decongestants, as well as immunotherapies. Selection of the optimal treatment approach depends on the temporal pattern, frequency, and severity of symptoms as well as the patient’s age. Nasal congestion is typically the most bothersome symptom, although rhinorrhea, postnasal drip, and ocular symptoms are also problematic. Together, these symptoms may adversely impact the quality of life, work productivity, sleep quality, and the ability to perform daily activities, particularly when uncontrolled. Practice guidelines recognize that INCSs are the most effective medications for controlling allergic rhinitis symptoms, including nasal congestion. Available INCS products have comparable safety and efficacy profiles, but they differ in formulation characteristics and sensory attributes. Several barriers can impede the use of INCSs, including concerns about safety, misperceptions regarding the loss of response from frequent use, and undesirable sensations associated with intranasal administration. Given the increasing number of INCSs available OTC, pharmacists can help allay these concerns by discussing treatment expectations, recommending INCS products with favorable formulation characteristics, and reviewing proper use and technique for the administration of the selected product. These steps can help to foster a collaborative relationship between the patient and the pharmacist in the treatment of allergic rhinitis. Dove Medical Press 2017-05-04 /pmc/articles/PMC5774310/ /pubmed/29354557 http://dx.doi.org/10.2147/IPRP.S129544 Text en © 2017 Bridgeman. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Bridgeman, Mary Barna Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis |
title | Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis |
title_full | Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis |
title_fullStr | Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis |
title_full_unstemmed | Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis |
title_short | Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis |
title_sort | overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774310/ https://www.ncbi.nlm.nih.gov/pubmed/29354557 http://dx.doi.org/10.2147/IPRP.S129544 |
work_keys_str_mv | AT bridgemanmarybarna overcomingbarrierstointranasalcorticosteroiduseinpatientswithuncontrolledallergicrhinitis |